Brief: Context Therapeutics Inc. Q2 basic EPS USD -0.31
09/08/2023 21:11
Aug 9 (Reuters) - Context Therapeutics Inc. Q2 basic EPS USD -0.31. * Q2 net income USD -5 million
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202